Hjem › Diffus sclerodermi › Texas › Houston
Diffus sclerodermi kliniske forsøg i Houston, TX
5 studier for Diffus sclerodermi søger deltagere på steder i og omkring Houston (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
RekruttererFase 2
- Prolato Clinical Research Center, Houston
- Novel Research LLC, Bellaire · 7 mi væk
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
RekruttererFase 2
- EncompaSSc site in Houston, TX, Houston
Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RekruttererFase 1/2
- Nkarta Investigational Site, Houston
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RekruttererFase 2
- Artiva Investigational Site Bellaire, Bellaire · 7 mi væk
Diffus sclerodermi forsøg i andre byer
- New York City, NY8 studier
- Ann Arbor, MI7 studier
- Chicago, IL7 studier
- Durham, NC6 studier
- Los Angeles, CA6 studier
- Boston, MA5 studier
- Baltimore, MD5 studier
- New Orleans, LA4 studier
- Pittsburgh, PA4 studier
- Kansas City, KS4 studier
- Philadelphia, PA4 studier
- Plantation, FL3 studier
Andre studier i Houston
- Ikke-småcellet lungecancer145 studier
- Brystkræft126 studier
- Kræft (alle typer)121 studier
- Metastatisk cancer104 studier
- Colorektal kræft102 studier
- Ægstockræft89 studier
- Akut myeloid leukæmi85 studier
- Lungecancer78 studier
- Prostatakræft76 studier
- Livmoderslimhindekræft68 studier
- Bugspytkirtelkræft61 studier
- Melanom59 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.